Latest Breaking News On - Lumos pharma daily - Page 1 : comparemela.com

Lumos Pharma (NASDAQ:LUMO) Posts Quarterly Earnings Results, Beats Expectations By $0 01 EPS

Lumos Pharma (NASDAQ:LUMO) Posts Quarterly Earnings Results, Beats Expectations By $0 01 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Lumos pharmaLumos pharma incAdvisor groupEnvestnet asset management incVirtu financialShay capitalMillennium managementGet free reportAsset managementLumos pharma daily

Lumos Pharma, Inc (NASDAQ:LUMO) Shares Bought by Greenwich Wealth Management LLC

Greenwich Wealth Management LLC boosted its position in shares of Lumos Pharma, Inc. (NASDAQ:LUMO – Free Report) by 55.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 76,341 shares of the company’s stock after acquiring an additional 27,339 shares during the period. Greenwich […]

Lumos pharmaLumos pharma incEnvestnet asset management incSecurities exchange commissionMillennium managementGreenwich wealth managementGeode capital managementAdvisor groupVirtu financialFree reportWealth managementAsset managementCapital managementGet free reportLumos pharma dailyNasdaq lumo

Lumos Pharma, Inc (NASDAQ:LUMO) Stock Holdings Increased by Greenwich Wealth Management LLC

Greenwich Wealth Management LLC lifted its stake in Lumos Pharma, Inc. (NASDAQ:LUMO – Free Report) by 55.8% in the third quarter, Holdings Channel.com reports. The firm owned 76,341 shares of the company’s stock after acquiring an additional 27,339 shares during the quarter. Greenwich Wealth Management LLC’s holdings in Lumos Pharma were worth $252,000 as of […]

Lumos pharmaAdvisor groupShay capitalLumos pharma incMillennium managementGreenwich wealth managementGeode capital managementHoldings channelJefferies financial group incFree reportWealth managementFinancial groupCapital managementGet free reportVisit holdingschannelLumos pharma daily

Lumos Pharma (NASDAQ:LUMO) Price Target Cut to $16 00 by Analysts at Oppenheimer

Lumos Pharma (NASDAQ:LUMO – Get Free Report) had its price objective cut by research analysts at Oppenheimer from $17.00 to $16.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price indicates a potential upside of 451.72% from the stock’s previous close. LUMO […]

Lumos pharmaGeode capital managementVirtu financialGreenwich wealth managementAdvisor groupShay capitalLumos pharma company profileCantor fitzgeraldLumos pharma incGet free reportWealth managementCapital managementLumos pharma dailyNasdaq lumoLower price targetOppenheimer holdings inc

Cantor Fitzgerald Reiterates Overweight Rating for Lumos Pharma (NASDAQ:LUMO)

Cantor Fitzgerald reiterated their overweight rating on shares of Lumos Pharma (NASDAQ:LUMO – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. They currently have a $10.00 price target on the stock. Several other research firms also recently issued reports on LUMO. Oppenheimer cut their price objective on Lumos Pharma […]

Lumos pharmaGeode capital managementGreenwich wealth managementCantor fitzgeraldAdvisor groupVirtu financialLumos pharma incMarquette asset managementFree reportPharma trading downCapital managementWealth managementAsset managementGet free reportLumos pharma dailyNasdaq lumo